上睑下垂
重编程
表观遗传学
癸他滨
癌症研究
免疫原性细胞死亡
基因沉默
细胞生物学
免疫系统
免疫疗法
体内
癌症免疫疗法
生物
程序性细胞死亡
DNA甲基化
癌细胞
癌症
表观遗传疗法
先天免疫系统
小发夹RNA
细胞凋亡
活性氧
化学
启动(农业)
肿瘤微环境
细胞
PD-L1
获得性免疫系统
作者
Fan Zhuang,Jingjing Li,Chenguang Shi,李翠仙,Beilei Lu,Mengqi Yan,Wei Wang,Huijing Xiang,Yu Chen,Beijian Huang
摘要
Pyroptosis, a pro-inflammatory form of cell death, elicits robust antitumor immune responses. However, pyroptosis-based cancer immunotherapy is hampered by the epigenetic silencing of gasdermin E (GSDME) through hypermethylation of the DFNA5 gene. To overcome this limitation, we engineered an innovative nanosystem by first synthesizing a reactive oxygen species (ROS)-responsive decitabine prodrug (DTO), which was subsequently encapsulated within hydrogen-bonded organic frameworks to form the HDTO nanoplatform. Upon ultrasound (US) activation, the HDTO nanoplatform exhibited potent ROS generation, enabling two complementary functions: (1) triggering decitabine release to demethylate DFNA5 and restore GSDME expression and (2) activating caspase-3, thereby initiating the caspase-3/GSDME-mediated pyroptotic pathway. This apoptosis-to-pyroptosis switching mechanism significantly enhanced immunogenic cell death and potentiated antitumor immunity. In vivo studies demonstrated that US-activated HDTO induced robust pyroptosis, remodeled the tumor microenvironment, and elicited superior antitumor immune responses, resulting in marked suppression of tumor growth and metastasis. Single-cell RNA sequencing analysis confirmed that HDTO + US-induced pyroptosis depleted nonimmune cells while expanding monocyte and neutrophil populations, demonstrating effective immunoreprogramming. This study establishes a novel therapeutic paradigm that synergistically integrates epigenetic modulation with pyroptosis induction to enhance the efficacy of cancer immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI